| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2005 | WO2005005414A3 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 04/21/2005 | WO2005004878A3 Multi-use vessels for vitamin d formulations, preferably administeredat high dose and periodically |
| 04/21/2005 | WO2005004867A3 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor |
| 04/21/2005 | WO2005004803A3 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/21/2005 | WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 04/21/2005 | WO2005002625A3 In-situ gelling drug delivery system |
| 04/21/2005 | WO2005002528A3 Method for treating diabetes |
| 04/21/2005 | WO2005000405A3 P38 kinase inhibitor compositions and methods of use |
| 04/21/2005 | WO2005000239A3 Lyase treatment for p. carinii |
| 04/21/2005 | WO2005000208A3 Combination therapy for the treatment of neoplasms |
| 04/21/2005 | WO2004111047A3 Cycloalkanepyrrolopyridines as dp receptor antagonists |
| 04/21/2005 | WO2004110992A3 Process for imidazo[4,5-c] pyridin-4-amines |
| 04/21/2005 | WO2004110361A3 Anticancer compositions comprising methenamine |
| 04/21/2005 | WO2004108142A3 Inhibitors of tip-1 for treatment tissue damage |
| 04/21/2005 | WO2004108119A3 Use of atp or derivatives in medicine |
| 04/21/2005 | WO2004106322A3 Polymorphs of aripiprazole |
| 04/21/2005 | WO2004105782A3 Drug delivery systems for tumor targeting ngr-molecules and uses thereof |
| 04/21/2005 | WO2004105678A3 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 04/21/2005 | WO2004104199A3 Modulation of gene expression using dna-dna hybrids |
| 04/21/2005 | WO2004100973A3 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases. |
| 04/21/2005 | WO2004100866A3 Alcohol-free transdermal analgesic composition |
| 04/21/2005 | WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 04/21/2005 | WO2004096285A3 Anti-infective phosphonate conjugates |
| 04/21/2005 | WO2004096237A3 Phosphonate analogs for treating metabolic diseases |
| 04/21/2005 | WO2004093995A3 Use of antioxidants to treat bone loss disorders |
| 04/21/2005 | WO2004093809A3 Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
| 04/21/2005 | WO2004091593A3 Methods for the treatment of pain comprising opioid antagonists |
| 04/21/2005 | WO2004091530B1 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
| 04/21/2005 | WO2004089291A3 Tumor-targeting drug-loaded particles |
| 04/21/2005 | WO2004089288A3 Method of treating lower urinary tract disorders |
| 04/21/2005 | WO2004089286A3 Novel compounds and compositions as protein kinase inhibitors |
| 04/21/2005 | WO2004078169A8 Use of ep2 selective receptor agonists in medical treatment |
| 04/21/2005 | WO2004069992A3 Oligomeric compounds for the modulation of ras expression |
| 04/21/2005 | WO2004045490A3 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 04/21/2005 | WO2004031174A8 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/21/2005 | WO2004028455A3 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 04/21/2005 | WO2004022076A8 Branched alpha-glucans for weight management |
| 04/21/2005 | WO2004021978A3 Antisense modulation of endothelial specific molecule 1 expression |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2003103612A3 Method of using prostacyclin to treat respiratory syncytial virus infections |
| 04/21/2005 | WO2003101421A8 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 04/21/2005 | WO2003096970A3 Methods and compositions for treating t cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency |
| 04/21/2005 | WO2003061584A3 Novel substituted benzimidazole dosage forms and method of using same |
| 04/21/2005 | WO2003049673A3 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 04/21/2005 | WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050085860 Transdermal/transmucosal preparations for electroporation |
| 04/21/2005 | US20050085758 Dilute aqueous solution containing epidermal growth factor in gel |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085652 Trans configuration; reacting 3-methyl butyric acid with halvaleric acid; forming 8-methyl-6-nonynoic acid; reduction; activation; acylation |
| 04/21/2005 | US20050085644 Antidiabetic agents; insulin resistance |
| 04/21/2005 | US20050085640 Novel crystalline forms of gatifloxacin |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085637 Pyrimidine compounds |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085557 Oxidation of cholesterol in atherosclerosis plaque; cytotoxic |
| 04/21/2005 | US20050085555 Composition, synthesis and therapeutic applications of polyamines |
| 04/21/2005 | US20050085554 Antiinflammatory agents; therapy for infections; anticancer agents; parasiticides; bactericides; nematocides; sponge extract; fermentation of micromonospora |
| 04/21/2005 | US20050085553 Remedies for mild recognition deflict |
| 04/21/2005 | US20050085552 Method for providing long-lasting pain relief through intrathecal administration of civamide |
| 04/21/2005 | US20050085551 Therapy for herpes virus |
| 04/21/2005 | US20050085549 Hetrocyclic aryl sulphonamides |
| 04/21/2005 | US20050085548 Administering mixture of arginine and reductase inhibitase; therapy for endothelial cell diseases; hypotensive agents; cardiovascular disorders brain disorders |
| 04/21/2005 | US20050085547 Molecules for inducing differentiation of dendritic cells |
| 04/21/2005 | US20050085546 Method of inducing differentiation of dendritic cells |
| 04/21/2005 | US20050085543 Genetic engineering; wound healing agents |
| 04/21/2005 | US20050085542 Solution for peritomeal dialysis |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085540 Compounds and methods for delivery of prostacyclin analogs |
| 04/21/2005 | US20050085539 Method of reducing toxicity of retinoids |
| 04/21/2005 | US20050085538 Administering strylacrylonitrile compound; antiproliferative agents; anticancer agents |
| 04/21/2005 | US20050085537 Method and composition for treating osteoporosis |
| 04/21/2005 | US20050085535 Lipase inhibiting polymers |
| 04/21/2005 | US20050085533 Central nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 04/21/2005 | US20050085532 Prevention, therapy of central nervous system disorders ; antidepressants; anxiolytic agents; eating and sleep disorders; Alzheimer's disease; strokes; schizophrenia; incontinence; gastrointestinal disorders; cardiovascular disorders |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085530 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/21/2005 | US20050085529 Prenylation inhibitors reduce host cell permissiveness to viral replication |
| 04/21/2005 | US20050085528 Anticholesterol agents; prenylation antagonist; hmg-coa reductase inhibitor; therapy for hepatitis virus infections |
| 04/21/2005 | US20050085525 Method of treatment |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085518 Aryl sulfonamides useful as inhibitors of chemokine receptor activity |
| 04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/21/2005 | US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 04/21/2005 | US20050085514 Psychological disorders; schizophrenia; anxiolytic agents; antidepressants; bipolar diseases; circadian rhythm disorders; analgesics; Parkinson's disease; Huntington's disease |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | US20050085510 Drug for gastrointestinal disorders |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085506 Novel gamma secretase inhibitors |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085503 used for detecting diseases where N-acetylated alpha -linked acidic dipeptidase (NAALADase) levels are altered, effecting neuronal activity, effecting TGF- beta activity, inhibiting angiogenesis, and treating glutamate abnormalities, cancer, pain |
| 04/21/2005 | US20050085502 Phenyl-substituted imidazopyridines |
| 04/21/2005 | US20050085501 Phenyl-substituted imidazopyridines |
| 04/21/2005 | US20050085500 Reacting arylmethylamine with 4-chloro-1H-imidazolo(4,5-c)quinoline |
| 04/21/2005 | US20050085499 Crystal structure; solvates; parkinson's disease |
| 04/21/2005 | US20050085498 a lipid soluble thiamine such as benfotiamine, creatine ethyl ester for example; reducing serum glucose levels and maintaining those reduced glucose levels over time to treat diabetic polyneuropathy, improving circulation |
| 04/21/2005 | US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |